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S2
NMR spectra of intermediates and products.
1-Benzyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid, 3a.
S3
Methyl 6-methoxynicotinate, 2b in DMSO.
S4
Methyl 1-benzyl-6-oxo-1,6-dihydropyridine-3-carboxylate, 3b.
S5
(6-Methoxypyridin-3-yl)methanol, 2c.
S6
1-Benzyl-5-(hydroxymethyl)pyridin-2(1H)-one, 3c .
S7
S8
1-Benzyl-6-oxopiperidine-3-carboxylic acid, (±)-4a.
S9
Methyl 1-benzyl-6-oxopiperidine-3-carboxylate, (±)-4b.
S10
1-Benzyl-3-hydroxymethyl 6-oxopiperidine (±)-4c.
S11
1-Benzyl-5-methylpiperidin-2-one, (±)-21.
S12
1-((6-Methoxypyridin-3-yl)methyl)piperidine-2,6-dione, 2d.
S13
1-[(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl]piperidine-2,6-dione 3d.
S14
S15
1-[(1-Benzyl-6-oxopiperidin-3-yl)methyl]piperidine-2,6-dione, (±)-4d.
S16
1-Benzyl-5-[(2-hydroxy-6-oxopiperidin-1-yl)methyl]piperidin-2-one, (±)-22.
S17
1-[(1-Benzyl-6-oxopiperidin-3-yl)methyl]-3,4-dihydropyridin-2(1H)-one, (±)-23.
S18
The selenoxide oxidation – elimination of enamide (±)-23, yielding (±)-1-((1-benzyl-6-oxopiperidin-3-
yl)methyl)pyridin-2(1H)-one, (±)-4e.
Product from reaction (crude mix with side-product), the position of 4e is indicated with * and is
partly masked by an inseparable by product:
S19
For comparison, a sample of authentic 4e is shown below:
S20
5-Chloromethyl-2-methoxypyridine, 24.
S21
1-((6-methoxypyridin-3-yl)methyl)pyridin-2(1H)-one 2e.
S22
2-methoxy-5-((pyridin-2-yloxy)methyl)pyridine, 25.
S23
S24
1-Benzyl-5-[(2-oxopyridin-1(2H)-yl)methyl]pyridin-2(1H)-one, 3e.
S25
S26
1-((1-Benzyl-6-oxopiperidin-3-yl)methyl)piperidin-2-one, (±)-26.
S27
1-Benzyl-3-(piperidin-1-ylmethyl)piperidine, (±)-1 (R=Bn).
S28
HMQC spectra of 1 (R=Bn), 700 MHz (1H), 176 MHz (13C) CDCl3.
S29
COSY 1 (R=Bn), 700 MHz (1H1,1H2), CDCl3.
1-(Piperidin-3-ylmethyl)piperidine, (±)-1 (R=H).
S30
S31
N,6-Dimethoxy-N-methylpyridine-3-carboxamide, 28.
S32
1-(6-Methoxypyridin-3-yl)ethanone, 5.
S33
5-Acetyl-1-benzylpyridin-2(1H)-one, 27.
S34
Entry ketonea R t / h g Prod.
Ee /
%
1 5b Methyl 21 (R)- 10h 83d
2 6 n-butyl 20 (R)-11i 76d
3 7 i-propyl 22 (R)-12i 53c
4 8 Cyclohexyl 24 (R)-13i 35f
5 9 Phenyl 24 (-)-14 48e
1-(4-Methoxyphenyl)pentan-1-one, 6.
S35
1-(6-Methoxypyridin-3-yl)-2-methylpropan-1-one, 7.
S36
Cyclohexyl(6-methoxypyridin-3-yl)methanone, 8.
S37
(6-Methoxypyridin-3-yl)(phenyl)methanone, 9.
S38
(S)-1-(6-Methoxypyridin-3-yl)ethanol, (S)-10.
S39
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(R)-1-(6-Methoxypyridin-3-yl)pentan-1-ol, (R)-11.
S41
Acetate derivative for ee determination:
S42
(R)-1-(6-Methoxypyridin-3-yl)-2-methylpropan-1-ol, (R)-12.
S43
(R)-Cyclohexyl(6-methoxypyridin-3-yl)methanol, (R)-13.
S44
(6-Methoxypyridin-3-yl)(phenyl)methanol, (-)-14.
S45
1-Benzyl-5-(1-hydroxyethyl)piperidin-2-one, (R)-15 sample from reduction of 27 in 42% ee.
(R)-1-(6-Methoxypyridin-3-yl)ethanol, (R)-10 (larger scale preparation).
S46
1-Benzyl-5-(1-hydroxyethyl)pyridin-2(1H)-one,(R)- 15 made from the pyridine 10.
Crude product:
S47
1-benzyl-5-(1-hydroxyethyl)piperidin-2-one, D1- 16a.
S48
1-benzyl-5-(1-hydroxyethyl)piperidin-2-one, D2-16b.
S49
S50
The hydrogenolysis product 1-benzyl-5-ethylpiperidin-2-one, 32.
S51
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5-Acetyl-1-benzylpyrimidine-2,4(1H,3H)-dione, 34.
S53
5-(1-hydroxyethyl)dihydropyrimidine-2,4(1H,3H)-dione, 35.
S54
1-Benzyl-5-(1-hydroxyethyl)dihydropyrimidine-2,4(1H,3H)-dione, 37a and b.
With (R,R)-catalyst 19:
S55
With (S,S)-catalyst 19:
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Chiral HPLC and GC Traces.
Compound (S)-10 (acetate derivative).
Racemic:
Sample of 82% ee (S):
S58
Compound 11 (rather than forming a racemate, reduction by each catalyst enantiomer was carried
out independently).
(R)-enantiomer 76% ee compound 11 (under condtions given in Table 5):
(S) enantiomer 67% ee:
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Compound 12:
Racemic:
(R)-product, 53% ee
S60
Compound 13
racemic:
S61
(R)-product, 35 % ee:
Compound 14
racemic
S62
Of 48% ee:
S63
Compound 15 racemic
S64
Of 42% ee formed by reduction of 27:
S65
Large scale reduction of 10 to give 15 in 78% ee (GC of acetate derivative):
Racemic standard:
78% ee sample (R) formed from 10:
S66
crude reduction mixture of 16a and 16b
This GC trace was obtained from the crude reaction mixture of (D1)-16a and (D2)-16b resulting from
the PtO2 reduction of pyridone (R)-15 (78 % ee). This was used to determine the dr of the reaction.
Chiral separation details: (CP – ChiraSil – DEX CB 25 m x 0.25 mm x 0.25 µm, gas: He, T = 200 °C, P =
18 psi He, det = 250 °C, inj = 220 °C, (S,R) isomer 24.49 min., (R,S) isomer 25.04 min., (S,S) isomer
25.57 min., (R,R) isomer 25.99 min.) 31 % de.
S67
Following chromatography of this crude mixture, the diastereomers D1-16a and D2-16b were
seprated. The GC traces of these isomers are shown below.
D1-16a, 78 % ee.
This GC trace was obtained from a chromatographically separated sample of D1-16a. Different GC
conditions (to those in GC trace 1) were required for adequate separation. The racemic standard for
this run is shown in GC trace 3. Chiral separation details: (CP – ChiraSil – DEX CB 25 m x 0.25 mm x
0.25 µm, gas: H, T = 185 °C, P = 18 psi H, det = 250 °C, inj = 220 °C, (S,R) isomer 18.61 min., (R,S)
isomer 19.24 min.) 78 % ee.
(±)-(D1)-16a (racemic standard).
This GC trace of (D1)- 16a was used as a racemic standard for GC trace 2: (CP – ChiraSil – DEX CB 25
m x 0.25 mm x 0.25 µm, gas: H, T = 185 °C, P = 18 psi H, det = 250 °C, inj = 220 °C, (S,R) isomer 18.64
min., (R,S) isomer 19.16 min.).
S68
(±)-D1-16a (in reference to GC 1).
This GC trace of racemic (D1)-16a was run at the same conditions as GC trace 1 to enable
comparison. Chiral separation details: (CP – ChiraSil – DEX CB 25 m x 0.25 mm x 0.25 µm, gas: He, T =
200 °C, P = 18 psi He, det = 250 °C, inj = 220 °C, (S,R) isomer 24.62 min., (R,S) isomer 25.11 min.).
GC trace 5: D2-16b, 78 % ee.
S69
This GC trace was obtained from a chromatographically enriched sample of D2-16b (72 % D2). The
racemic standard is shown in GC trace 6. Chiral separation details: (CP – ChiraSil – DEX CB 25 m x
0.25 mm x 0.25 µm, gas: H, T = 200 °C, P = 18 psi He, det = 250 °C, inj = 220 °C, (S,R) isomer 24.48
min., (R,S) isomer 25.00 min. (S,S) isomer 25.54 min., (R,R) isomer 26.09 min.) 78 % ee.
GC trace 6: (±)-D2-16b.
This GC trace of (±)-D2-16b was used as a racemic standard for GC trace 5. Chiral separation details:
(CP – ChiraSil – DEX CB 25 m x 0.25 mm x 0.25 µm, gas: He, T = 200 °C, P = 18 psi He, det = 250 °C, inj
= 220 °C, (S,S) isomer 25.52 min., (R,R) isomer 25.99 min.).
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ATH of N-benzyl-5-acetyluracil 34.
Reduction with the racemic catalyst, RuTsEN 36, (entry 2, Table 6); chiral separation details:
(Chiralpak IA, 4.6 mm x 250 mm, hexane : IPA 90 : 10, 1 mL/min, T = 30 °C, minor isomer 46.0 min,
major isomer 51.9 min.) 37a:37b dr = 1:1.
Reduction with catalyst (R,R)-20, (entry 3, Table 6); chiral separation details: (Chiralpak IA, 4.6 mm x
250 mm, hexane : IPA 90 : 10, 1 mL/min, T = 30 °C) 37a: 55 % ee; 37b: 36 % ee. a : b dr = 1.3:1.
S71
Reduction with (R,R)-RutethTsDPEN, (R,R)-19, (entry 4, Table 6); chiral separation details: (Chiralpak
IA, 4.6 mm x 250 mm, hexane : IPA 90 : 10, 1 mL/min, T = 30 °C) 37a: 92 % ee; 37b: 33 % ee. a : b dr =
4:1.
S72
Reduction with (S,S)-RutethTsDPEN, (S,S)- 19, (entry 5, Table 6); chiral separation details: (Chiralpak
IA, 4.6 mm x 250 mm, hexane : IPA 90 : 10, 1 mL/min, T = 30 °C) 37a: 86 % ee; 37b: 49 % ee. a : b dr =
4:1.
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X-ray crystallographic structures.
5-Acetyl-1-benzylpyrimidine-2,4(1H,3H)-dione, 34. CCDC 992397.
This structure was determined by the EPSRC Crystallographic Service. Crystallographic data for 34:
C13H12N2O3, M = 244.25, Monoclinic, space group P2(1)/n, a = 9.680(15), b = 23.71(3), c = 10.025(13)
Ǻ, alpha = 90 deg., beta = 97.78(3) deg., gamma = 90 deg., U = 2280(5) Ǻ3 (by least squares
refinement on 453 reflection positions), T =100(2)K, lambda = 0.71075 Ǻ, Z =  8, D(cal) = 1.423 
Mg/m3, F(000) = 1024. mν (MoK-alpha) =  0.103 mm-1. Crystal character: colourless needle. Crystal
dimensions 0.20 x 0.01 x 0.01 mm, 25462 reflections measured, 5220 unique [R(int) = 0.0623].
1-[(1-Benzyl-6-oxo-1,6-dihydropyridin-3-yl)methyl]piperidine-2,6-dione, 3d. CCDC 992395.
Crystallographic data for 3d: C18H18N2O3, M = 310.34, Orthorhombic, space group Pbca, a =
8.60003(9), b = 17.41730(19), c = 20.1379(3)Ǻ, α = 90 deg., β = 90 deg., γ = 90 deg., U = 3016.45(6) 3 
Ǻ (by least squares refinement on 9775 reflection positions), T =100(2)K, lambda = 1.54184 Ǻ, Z =  8, 
D(cal) = 1.367 Mg/m3, F(000) = 1312. mν(MoK-alpha) = 0.766 mm-1. Crystal character: colourless
block. Crystal dimensions 0.40 x 0.40 x 0.28 mm, 15826 reflections measured, 2892 unique [R(int) =
0.0173].
S74
1-Benzyl-5-[(2-oxopyridin-1(2H)-yl)methyl]pyridin-2(1H)-one, 3e. CCDC 992396.
Crystallographic data for 3e. C18H16N2O2, M = 292.33, Monoclinic, space group P2(1)/n, a =
13.0964(3), b = 7.73187(14), c = 15.1103(3) Ǻ, alpha = 90 deg., beta = 108.983(2) deg., gamma = 90 
deg., U = 1446.85(5) A3 (by least squares refinement on 2682 reflection positions), T =150(2)K,
lambda = 1.54184 Ǻ, Z =  4, D(cal) = 1.342 Mg/m3, F(000) = 616. mν (MoK-alpha) =  0.714 mm-1.
Crystal character:colourless plate. Crystal dimensions 0.20 x 0.20 x 0.01 mm. 5296 reflections
measured, 2543 unique [R(int) = 0.0216].
1-benzyl-5-(1-hydroxyethyl)piperidin-2-one, anti-D1-16a. CCDC 992398.
Crystal Data for 16a: C14H19NO2, M = 233.30, Orthorhombic, space group Pna2(1), a = 10.7915(2), b =
21.1078(5), c = 5.64620(18) Ǻ, alpha = 90 deg., beta = 90 deg., gamma = 90 deg., U = 1286.11(6) Ǻ3
(by least squares refinement on 5741 reflection positions), T =150(2)K, lambda = 1.54184 Ǻ, Z =  4, 
D(cal) = 1.205 Mg/m^3, F(000) = 504. Mν (MoK-alpha) = 0.638 mm-1. Crystal character: colourless
needle. Crystal dimensions 0.50 x 0.01 x 0.01 mm, 10079 reflections measured, 2146 unique [R(int) =
0.0250].
